This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
AB InBev (BUD) Q4 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
AB InBev's (BUD) top and bottom lines for the fourth quarter gain from ongoing revenue management initiatives along with strong performance of premium brands.
ETFs and Stocks to Tap the Marijuana Boom
by Sweta Killa
First it was bitcoin that made investors go on a mad rush, and today, it's marijuana. Now that legalization is steadily gaining traction across the U.S., more investors than ever before are looking for ways to cash in.
Boston Beer's (SAM) Earnings & Revenues Top Estimates in Q4
by Zacks Equity Research
Boston Beer (SAM) delivers better-than-expected results in fourth-quarter 2018. For 2019, it remains confident about depletions and shipments growth.
4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
by Sanghamitra Saha
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.
Why Marijuana ETFs are on a High in 2019
by Sweta Killa
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.
Molson Coors (TAP) Q4 Earnings Beat, Soft Volume Hurts Sales
by Zacks Equity Research
Positive pricing, strength in Europe and International, and cost savings aid Molson Coors' (TAP) Q4 earnings. Soft global brand volume due to weak demand in the United States and Canada hurts sales.
Moving Average Crossover Alert: Diageo
by Zacks Equity Research
Diageo plc (DEO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
Here's Why Momentum Investors Will Love Diageo (DEO)
by Zacks Equity Research
Does Diageo (DEO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Research Reports for Pepsico, Walt Disney & Sanofi
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pepsico (PEP), Walt Disney Company (DIS) and Sanofi (SNY).
Diageo (DEO) Posts Strong 1H19 Earnings, Ups FY19 Sales View
by Zacks Equity Research
Diageo (DEO) reports strong top and bottom-line results for the first half of fiscal 2019, backed by solid organic growth. Further, the outlook for fiscal 2019 remains robust.
What Makes Marijuana ETF the Best Performer in January?
by Sanghamitra Saha
These are the factors that led marijuana ETF to see a strong start to 2019.
Expansion & Innovation to Aid Diageo's (DEO) 1H19 Earnings
by Zacks Equity Research
Diageo (DEO) witnesses solid trends, backed by the focus on expanding geographic footprint and launching innovative products. This should continue to drive earnings in the quarters ahead.
Why Marijuana ETF is on a High in 2019
by Sweta Killa
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback this year on the renewed appeal for riskier assets.
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
by Sanghamitra Saha
These are the factors that could send marijuana stocks and ETF high in 2019.
The Zacks Analyst Blog Highlights: Merck, Mastercard, Salesforce, Diageo and State Street
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Mastercard, Salesforce, Diageo and State Street
Top Stock Reports for Merck, Mastercard & Salesforce
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Mastercard (MA) and Salesforce (CRM).
Stock Market News For Nov 13, 2018
by Zacks Equity Research
U.S. stock markets plunged on Monday as record drop in shares of Apple and Goldman Sachs, and precipitous decline of crude oil price significantly dented investor confidence
Diageo to Offload 19 Brands to Sazerac, Can This Aid Growth?
by Zacks Equity Research
Diageo (DEO) agrees to sell its 19 brands, including Seagram's VO whiskey, to Sazerac for a total consideration of $550 million.
Marijuana ETF Enters Bear Territory: What Lies Ahead?
by Sweta Killa
Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.
Moving Average Crossover Alert: Diageo (DEO)
by Zacks Equity Research
Diageo plc (DEO) could be a stock to avoid from a technical perspective
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Diageo, Constellation Brands, Cara, Cronos and GW
ETFs & Stocks to Tap Marijuana Boom
by Sweta Killa
Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.